$CXDO

Crexendo Eyes $100M Run Rate as AI, Acquisitions Fuel UCaaS Growth

Crexendo (CXDO) reported $45M in H1 revenue, up 49% YoY, with 12 consecutive profitable quarters. It aims for a $100M annualized run rate by 2026 and $150M by 2028. The company acquired ESI for $35M, adding 75K seats. Crexendo launched AI products like CAIRO, expecting higher revenue per customer.

Original reporting
Published Oct 22, 2026, 7:02 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 7:30 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Crexendo Eyes $100M Run Rate as AI, Acquisitions Fuel UCaaS Growth — source image
Decision brief

The 30-second read

$CXDOBullishMed
01

Why it matters

The disclosed revenue growth, acquisition details, and $100M run‑rate guidance provide fresh material that could re‑price the stock.

02

Market read

First‑time disclosure of H1 results and forward guidance makes this a material news event for CXDO investors.

03

What to watch

Potential competitive pressure from larger rivals like RingCentral and 8x8 could limit market share gains.

Relevance 6/10Novelty 6/10Timing: pre‑market today

Background

Crexendo (NASDAQ:CXDO) is a cloud communications provider targeting growth through AI services and strategic acquisitions.

Company-level read

Ticker impact

$CXDOBullishHigh confidence
Context

Crexendo disclosed H1 revenue of $45M, 49% Q2 growth, a $35M acquisition, and guidance to reach $100M run‑rate by year‑end.

Expected impact

likely upward pressure as market prices in higher revenue run‑rate guidance

Evidence & confidence

New financial results and forward guidance are primary disclosures that can move the stock.

Market effects

UCaaS and cloud communications sector may see renewed interest as Crexendo highlights AI‑driven revenue opportunities.

U.S. small‑cap communication software segment could benefit from the growth narrative.

Limited to investors tracking emerging UCaaS players.

Counterpoint

The $35M acquisition could strain cash flow; execution risk may outweigh the upside from AI products.

Key entities

  • Crexendo, Inc.

    NASDAQ‑listed UCaaS provider.

  • ESI

    Dallas‑based software licensee acquired for $35M.

Related articles

$CXDOMed

Crexendo Announces Strong Second Quarter 2026 Results

Crexendo, Inc. (CXDO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Crexendo Announces Strong Second Quarter 2026 Results PHOENIX, AZ / ACCESSWIRE / August 4, 2026 / Crexendo, Inc. (NASDAQ: CXDO), an award-winning software technology company that is a premier provider of cloud communication platform software and unified communication

$PAYMed

10 Best Growth Stocks to Buy with Low P/E Ratios

The article screens for growth stocks with average revenue growth of at least 30% over five years and forward P/E below 25, then ranks them by forward P/E. It highlights Paymentus (PAY) with forward P/E 22.92 and 31.72% revenue growth; Wedbush raised its target to $36 and Baird to $34 after strong Q1 results and raised 2026 guidance. It also cites Crexendo (CXDO) with forward P/E 18.73 and 32.99% growth; Needham raised its target to $12 after strong Q1 organic telecom growth and deal wins.

$DMCHighAI 9/10

Why is DMC Global stock surging today?

DMC Global (BOOM) stock rose 16% in pre-market trading after reporting Q3 earnings that exceeded estimates, with EPS of $0.48 vs. $0.11 consensus and revenue of $172.8M vs. $161.1M. Adjusted EBITDA increased 59% YoY to $13.6M, and net debt fell to $13.7M. Management guided Q4 revenue between $154M-$164M, roughly in line with analyst expectations. The company cited strong performance in its Arcadia and NobelClad divisions, as well as a constructive broader market backdrop.

$ULMed

Why is Unilever stock sliding today?

Unilever (ULVR) shares fell 3.0% to 4,744.5p after Q3 2026 results showed 5.2% sales growth, beating estimates but missing investor expectations due to volume deceleration. Turnover rose 6.7% to €13.3B. The Wellbeing division declined, and Foods saw minimal growth. UBS cut its target, while Bernstein maintained a Buy rating. The stock traded near session lows, down from 4,892.5p. The FTSE 100 was set to open lower.